Let me verify the parent company details and the litigation context.
Olympus Corporation of the Americas (OCA) is the regional business center for Olympus Corporation (Tokyo) across the U.S., Canada and Latin America, headquartered at 3500 Corporate Parkway, Center Valley, Pennsylvania. It operates under the trade name Olympus America Inc. (FDA establishment registration confirms the two names together) and dates its U.S. presence to 1968, with the Center Valley regional headquarters opened in 2006. It is a wholly owned subsidiary of Olympus Corporation, a public company listed on the Tokyo Stock Exchange (TYO: 7733), which reported roughly ¥997 billion (~$6.5B) revenue for FY2025 and is headquartered in Hachioji/Tokyo (founded 1919). OCA states it employs "more than 5,200" people in North and South America; third-party revenue estimates for the subsidiary vary widely ($1B–$3B) and should be treated as unverified.
Products / operations. OCA is an operating medical-technology company, not an NPE. It sells and services the parent's medical product lines: gastrointestinal and surgical endoscopes and video imaging systems, endoscopic treatment instruments, and surgical energy/therapeutic devices, plus related clinical and service offerings. Olympus has narrowed its portfolio to medical technology: it transferred its Imaging (camera/audio) business to Japan Industrial Partners' OM Digital Solutions in 2021, and divested its Scientific Solutions (microscopes, industrial inspection) business to Bain Capital's Evident Corporation in 2023. Those businesses are no longer part of the Olympus portfolio.
Patent-litigation posture. OCA is a pure defendant in the tracked data — 0 cases as plaintiff, 1 as defendant — consistent with an operating company defending against third-party assertions rather than an entity asserting its own patents.
Notable case. The single tracked matter is Intellectual Ventures I LLC et al. v. Canon Inc. et al. (D. Del., filed 2011-09-09), in which Intellectual Ventures — a large patent-holding/licensing entity founded by Nathan Myhrvold — asserted nine patents covering digital image sensors, image magnification, and touch-screen display against Canon, Olympus and Nikon camera manufacturers. The Olympus defendants were dismissed with prejudice in December 2012 following a settlement; the suit continued only against Canon. The case was filed in the District of Delaware, not the Eastern District of Texas. No other litigation involving OCA appears in the tracked dataset.